Governments should use patents to shape the deployment of CRISPR–Cas9 as they have done for past technologies, argues Shobita Parthasarathy.
Read more
Use the patent system to regulate gene editing
Posted in bioengineering, biotech/medical
Posted in bioengineering, biotech/medical